Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 297, Issue 4, 2009, Pages

  Bonen, Arend ^a   Holloway, Graham P ^a   Tandon, Narendra N ^b   Han, Xiao Xia ^a   McFarlan, Jay ^a   Glatz, Jan F C ^c   Luiken, Joost J F P ^c  

^a UNIVERSITY OF GUELPH   (Canada)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

FAT CD36; Giant vesicles; GLUT4; Mitochondria; Plasma membrane associated fatty acid binding protein

Indexed keywords

CD36 ANTIGEN; FATTY ACID; FATTY ACID TRANSPORTER; GLUCOSE TRANSPORTER 4; INSULIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FAST MUSCLE; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HEART MUSCLE; HEART MUSCLE METABOLISM; INSULIN RESISTANCE; LIPID METABOLISM; LIPID OXIDATION; MALE; MITOCHONDRION; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOLEMMA; SKELETAL MUSCLE; SLOW MUSCLE; UPREGULATION; ZUCKER DIABETIC FATTY RAT;

ANIMALS; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CITRATE (SI)-SYNTHASE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FATTY ACIDS; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RESISTANCE; MALE; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; MYOCARDIUM; OBESITY; OXIDATION-REDUCTION; RATS; RATS, ZUCKER; THINNESS; TIME FACTORS; TRIGLYCERIDES;

EID: 70349617679     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.90820.2008     Document Type: Article

References (60)

1. Alkhateeb H, Chabowski A, Glatz JF, Luiken J, Bonen A. Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity. Am J Physiol Endocrinol Metab 293: E783-E793, 2007. (Pubitemid 47358991)
2. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55: 2277-2285, 2006. (Pubitemid 44743625)
3. Benton CR, Nickerson J, Lally J, Han XX, Holloway GP, Glatz JFC, Luiken JJFP, Graham TE, Heikkila JJ, Bonen A. Modest PGC-1α overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in SS, not IMF, mitochondria. J Biol Chem 283: 4228-4240, 2008.
4. Berk PD, Wada H, Horio Y, Potter BJ, Sorrentino D, Zhou SL, Isola LM, Stump D, Kiang CL, Thung S. Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related. Proc Natl Acad Sci USA 87: 3484-3488, 1990. (Pubitemid 20173660)
5. Berk PD, Zhou SL, Kiang CL, Stump D, Bradbury M, Isola L. Uptake of long chain fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J Biol Chem 272: 8830-8835, 1997. (Pubitemid 27147855)
6. Bonen A, Chabowski A, Luiken JJFP, Glatz JFC. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda) 22: 15-29, 2007.
7. Bonen A, Luiken JJFP, Arumugam Y, Glatz JFC, Tandon NN. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem 275: 14501-14508, 2000. (Pubitemid 30339737)
8. Bonen A, Luiken JJFP, Lui S, Dyck DJ, Kiens B, Kristiansen S, Turcotte L, van der Vusse GJ, Glatz JFC. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol Endocrinol Metab 275: E471-E478, 1998. (Pubitemid 28436067)
9. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JFC, Luiken JJFP, Heigenhauser GJF, Dyck DJ. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18: 1144-1146, 2004. (Pubitemid 39561551)
10. Bradbury MW, Berk PD. Mitochondrial aspartate aminotransferase: direction of a single protein with two distinct functions to two subcellular sites does not require alternative splicing of the mRNA. Biochem J 345: 423-427, 2000.
11. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJFP, Glatz JFC, Bonen A. A novel function for FAT/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 279: 36335-36341, 2004. (Pubitemid 39128959)
12. Carley AN, Atkinson LA, Bonen A, Harper ME, Kunnathu S, Lopaschuk GD, Severson DL. Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 d/db mice. Arch Physiol Biochem 113: 65-75, 2007. (Pubitemid 46904760)
13. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 1734: 112-126, 2005.
14. Cechetto JD, Sadacharan SK, Berk PD, Gupta RS. Immunogold localization of mitochondrial aspartate aminotransferase in mitochondria and on the cell surface in normal rat tissues. Histol Histopathol 17: 353-364, 2002.
15. Chabowski A, Chatham JC, Tandon NN, Calles-Escandon J, Glatz JFC, Luiken JJFP, Bonen A. Fatty acid transport and FAT/CD36 are increased in red but not in white muscle skeletal muscle of Zucker diabetic fatty (ZDF) rats. Am J Physiol Endocrinol Metab 291: E675-E682, 2006. (Pubitemid 44352276)
16. Chatham JC, Seymour AM. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res 55: 104-112, 2002.
17. Chavez JA, Holland WL, Bar J, Sandhoff K, Summers SA. Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J Biol Chem 280: 20148-20153, 2005. (Pubitemid 41379546)
18. Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, Summers SA. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278: 10297-10303, 2003. (Pubitemid 36800291)
19. Coort SLM, Hasselbaink DM, Koonen DYP, Willems J, Coumans WA, Chabowski A, van der Vusse GJ, Bonen A, Glatz JFC, Luiken JJFP. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats. Diabetes 53: 1655-1663, 2004. (Pubitemid 38857021)
20. Etgen GJ, Oldham BA. Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. Metabolism 49: 684-688, 2000.
21. Friedman JE, De Vente JE, Peteson RG, Dohm GL. Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa). Am J Physiol Endocrinol Metab 261: E782-E788, 1991.
22. Garcia-Roves P, Huss JM, Han DH, Hancock CR, Iglesias-Gutierrez E, Chen M, Holloszy JO. Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci USA 104: 10709-10713, 2007. (Pubitemid 47185729)
23. Han XX, Chabowski A, Tandon NN, Calles-Escandon J, Glatz JF, Luiken JJ, Bonen A. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle. Am J Physiol Endocrinol Metab 293: E566-E575, 2007.
24. He J, Kelley DE. Muscle glycogen content in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 287: E1002-E1007, 2004. (Pubitemid 39382939)
25. Hegarty BD, Cooney GJ, Kraegen EW, Furler SM. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51: 1477-1484, 2002.
26. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, Nelson DH, Karathanasis SK, Fontenot GK, Birnbaum MJ, Summers SA. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5: 167-179, 2007. (Pubitemid 46317299)
27. Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA. Lipid mediators of insulin resistance. Nutr Rev 65: S39-S46, 2007.
28. Holloszy JO, Booth FW. Biochemical adaptations to endurance exercise in muscle. Annu Rev Physiol 38: 273-291, 1976.
29. Holloway GP, Benton CR, Mullen KL, Yoshida Y, Snook LA, Han XX, Glatz JF, Luiken JJ, Lally J, Dyck DJ, Bonen A. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am J Physiol Endocrinol Metab 296: E738-E747, 2009.
30. Holloway GP, Jain SS, Han XX, Glatz JFC, Luiken JJFP, Bonen A. FAT/CD36 null mice reveal that mitochondrial FAT/CD36 is required to up-regulate mitochondrial fatty acid oxidation in contracting muscle. Am J Physiol Regul Integr Comp Physiol. First published July 22, 2009; doi:10.1152/ajpregu.91021. 2008.
31. Holloway GP, Lally J, Nickerson JG, Alkhateeb H, Snook LA, Heigenhauser GJ, Calles-Escandon J, Glatz JF, Luiken JJ, Spriet LL, Bonen A. Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle. J Physiol 582: 393-405, 2007. (Pubitemid 46993583)
32. Holloway GP, Thrush AB, Heigenhauser GJ, Tandon NN, Dyck DJ, Bonen A, Spriet LL. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women. Am J Physiol Endocrinol Metab 292: E1782-E1789, 2007.
33. Jain SS, Chabowski A, Snook LA, Schwenk RW, Glatz JFC, Luiken JJFP, Bonen A. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Lett 583: 2294-2300, 2009.
34. Kampf JP, Kleinfeld AM. Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane. Physiology (Bethesda) 22: 7-14, 2007.
35. Kampf JP, Kleinfeld AM, Bonen A, Chabowski A, Luiken JJFP, Glatz JFC. Is membrane transport of FFA mediated by lipid, protein, or both? Points of agreement. Physiology (Bethesda) 22: 29, 2007.
36. Kelley DA, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance. A reexamination. Diabetes 49: 677-683, 2000. (Pubitemid 30339979)
37. Koonen DPY, Coumans WA, Arumugam Y, Bonen A, Glatz JFC, Luiken JJFP. Giant membrane vesicles as a model to study cellular substrate uptake dissected from metabolism. Mol Cell Biochem 239: 121-130, 2002. (Pubitemid 35385803)
38. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7: 45-56, 2008.
39. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. β-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc Natl Acad Sci USA 91: 10878-10882, 1994. (Pubitemid 24985069)
40. Luiken JJFP, Arumugam Y, Bell RC, Calles-Escandon J, Tandon NN, Glatz JFC, Bonen A. Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am J Physiol Endocrinol Metab 282: E612-E621, 2002. (Pubitemid 35230500)
41. Luiken JJFP, Arumugam Y, Dyck DJ, Bell RC, Pelsers ML, Turcotte LP, Tandon NN, Glatz JFC, Bonen A. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 276: 40567-40573, 2001. (Pubitemid 37373196)
42. Luiken JJFP, Coort SML, Willems J, Coumans WA, Bonen A, van der Vusse GJ, Glatz JFC. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52: 1627-1634, 2003. (Pubitemid 36792449)
43. Luiken JJFP, Dyck DJ, Han XX, Tandon NN, Arumugam Y, Glatz JFC, Bonen A. Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. Am J Physiol Endocrinol Metab 282: E491-E495, 2002. (Pubitemid 34654821)
44. Luiken JJFP, Koonen DPY, Willems J, Zorzano A, Fischer Y, van der Vusse GJ, Bonen A, Glatz JFC. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51: 3113-3119, 2002.
45. Luiken JJFP, Turcotte LP, Bonen A. Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J Lipid Res 40: 1007-1016, 1999. (Pubitemid 29287871)
46. Mogensen M, Sahlin K, Fernstrom M, Glintborg D, Vind BF, Beck-Nielsen H, Hojlund K. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56: 1592-1599, 2007. (Pubitemid 46842617)
47. Nickerson JG, Alkhateeb H, Benton CR, Lally J, Nickerson J, Han XX, Wilson MH, Jain SS, Snook LA, Glatz JFC, Chabowski A, Luiken JJFP, Bonen A. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1, and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J Biol Chem 284: 16522-16530, 2009.
48. Ouwens DM, Diamant M, Foddor M, Habets D, Pelsers MMAL, El Hanaoui M, Dang ZC, van den Brom CE, Vlasblom R, Rietdijk A, Boer C, Coort SML, Glatz JFC, Luiken JJFP. Cardiac contractile dysfunction in insulin-resistant rats fed a high fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia 50: 1938-1948, 2007.
49. Sakamoto K, Goodyear LJ. Intracellular signaling in contracting skeletal muscle. J Appl Physiol 93: 369-383, 2002.
50. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000.
51. Slieker LJ, Sundell KL, Heath WF, Osborne HE, Bue J, Manetta J, Sportsman JR. Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a). Diabetes 41: 187-193, 1992.
52. Smith AC, Mullen KL, Junkin KA, Nickerson J, Chabowski A, Bonen A, Dyck DJ. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia. Am J Physiol Endocrinol Metab 293: E172-E181, 2007.
53. Srere PA. Citrate synthase. In: Methods of Enzymology, edited by Lowenstein JM. New York, Academic, 1969, p. 2-11.
54. Stratford S, Hoehn KL, Liu F, Summers SA. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem 279: 36608-36615, 2004. (Pubitemid 39129005)
55. Stump DD, Zhou SL, Berk PD. Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am J Physiol Gastrointest Liver Physiol 265: G894-G902, 1993. (Pubitemid 23349855)
56. Turcotte LP, Raney MA, Todd MK. ERK1/2 inhibition prevents contraction-induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle. Acta Physiol Scand 184: 131-139, 2005.
57. Wang P, Chatham JC. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286: E725-E736, 2004. (Pubitemid 38506943)
58. Wang PG, Lloyd SG, Zeng H, Bonen A, Chatham JC. The impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 288: H2102-H2110, 2005. (Pubitemid 40604093)
59. Wilkes J, Bonen A, Bell RC. A modified high-fat diet induces insulin resistance in rat skeletal muscle but not adipocytes. Am J Physiol Endocrinol Metab 275: E679-E686, 1998. (Pubitemid 128732056)
60. Yoshida Y, Holloway GP, Ljubicic V, Hatta H, Spriet LL, Hood D, Bonen A. Negligible direct lactate oxidation in subsarcolemmal and intermyofibrillar mitochondria obtained from red and white rat skeletal muscle. J Physiol 582: 1317-1335, 2007.